ABT - Abbott Laboratories
This page shows which of the focused investors we track hold ABT and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2018 it was held by 8 managers with an aggregate reported value of $338.34M, which is 0.04% of the combined portfolio.
As of Q4 2018, 8 tracked institutional managers held ABT (Abbott Laboratories) with an aggregate reported value of $338.34M — 0.04% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades ABT — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2018
- Ticker
- ABT
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Mairs & Power Growth Fund - Mairs & Power Growth Fund | 3.09% | Reduce -7.8% | 3,167,495 | $229.11M |
| 2 | Stanley Druckenmiller - Duquesne Family Office LLC | 5.43% | Add +77.0% | 1,295,700 | $93.72M |
| 3 | Jensen Investment Management - Jensen Investment Management | 0.12% | Reduce -0.7% | 120,057 | $8.68M |
| 4 | Steven Check - Check Capital Management | 0.26% | Reduce -5.0% | 39,850 | $2.88M |
| 5 | Dodge & Cox - Dodge & Cox | 0.00% | - | 32,829 | $2.38M |
| 6 | Thomas Russo - Gardner Russo & Quinn | 0.01% | - | 13,960 | $1.01M |
| 7 | First Pacific Advisors - First Pacific Advisors | 0.00% | Reduce -64.6% | 4,950 | $358K |
| 8 | Yacktman Asset Management - Yacktman Asset Management | 0.00% | - | 2,800 | $203K |
Loading holder history for ABT…